Revance Therapeutics Inc (RVNC)

[Emannow]

I agree the MedSpa Chains typically make 15% Net Profit. They are less profitable and have more issues than the Owner Operated Practices. The MedSpa Chains typically attract the price sensitive patients which is why the MedSpa Chains have not adopted the higher priced Daxi Toxin. MedSpa patients have limited funds, If RVNC drops the prices for Daxi, many MedSpa Chains will begin offering this product, do to the higher profit margin,

Owner Operated Aesthetic Practices are selling Daxi. If Patients begin to request Daxi, the sales will increase very quickly. The number 1 Barrier to purchase for all Aesthetic Patients is "Price", Each patient has XXX dollars and they allocated this amount to the products which give them the best overall outcome! RVNC has been recommending a price of $9.75 per unit...a patient gets 100 units, the cost is $975....versus 50 units of Botox at $12 costs $600. less $50 = $550...the price premium for Daxi is too much...Daxi should be 10% to 15% premium...should cost $650 for Daxi and then patients would be asking for the Daxi and sales would boom!

JMHO